Suchergebnisse - "Shinoda, Masahiro"

PubPharm (378)

31

Early Dynamics of MELD Scores Predict Corticosteroid Responsiveness to Severe Acute-Onset Autoimmune Hepatitis

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2022

von Noguchi, F. | Chu, P. | Yoshida, A. | +13

32

A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)

enthalten in: BMC medicine | 2022

von Kinoshita, T. | Shinoda, M. | Nishizaki, Y. | +11

ErratumIn: BMC Med. 2022 Dec 8;20(1):478. - PMID 36482439

33

A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)

enthalten in: BMC medicine | 2022

von Kinoshita, T. | Shinoda, M. | Nishizaki, Y. | +11

34

A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)

enthalten in: BMC medicine | 2022

von Kinoshita, T. | Shinoda, M. | Nishizaki, Y. | +11

35

Development of a risk score model for 1-year graft loss after adult deceased donor liver transplantation in Japan based on a 20-year nationwide cohort

enthalten in: Annals of gastroenterological surgery | 2022

von Takemura, Y. | Shinoda, M. | Takemura, R. | +11

36

Factors Associated with Low IgG Response to mRNA COVID-19 Vaccine BNT162b2

enthalten in: ResearchSquare.com | 2022

von Sugawa, S. | Nishimura, M. | Ota, S. | +6

37

Immunogenicity and safety of booster dose of S-268019-b or BNT162b2 in Japanese participants : An interim report of phase 2/3, randomized, observer-blinded, noninferiority study

enthalten in: Vaccine | 2022

von Shinkai, M. | Sonoyama, T. | Kamitani, A. | +8

38

A prospective feasibility study of one-year administration of adjuvant S-1 therapy for resected biliary tract cancer in a multi-institutional trial (Tokyo Study Group for Biliary Cancer: TOSBIC01)

enthalten in: ResearchSquare.com | 2022

von Itano, O. | Takemura, Y. | Kishida, N. | +22

39

A prospective feasibility study of one-year administration of adjuvant S-1 therapy for resected biliary tract cancer in a multi-institutional trial (Tokyo Study Group for Biliary Cancer: TOSBIC01)

enthalten in: ResearchSquare.com | 2022

von Itano, O. | Takemura, Y. | Kishida, N. | +22

40

Reappraisal of liver transplantation for erythropoietic protoporphyria : A deadly combination of disease recurrence and biliary complication

enthalten in: Pediatric transplantation | 2022

von Endo, Y. | Hibi, T. | Shinoda, M. | +13